Importer of Controlled Substances Registration: Siegfried USA, LLC, 30343-30344 [2016-11414]

Download as PDF 30343 Federal Register / Vol. 81, No. 94 / Monday, May 16, 2016 / Notices accordance with section 210.13 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be considered by the Commission if received not later than 20 days after the date of service by the Commission of the complaint and the notice of investigation. Extensions of time for submitting responses to the complaint and the notice of investigation will not be granted unless good cause therefor is shown. Failure of a respondent to file a timely response to each allegation in the complaint and in this notice may be deemed to constitute a waiver of the right to appear and contest the allegations of the complaint and this notice, and to authorize the administrative law judge and the Commission, without further notice to the respondent, to find the facts to be as alleged in the complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of an exclusion order or a cease and desist order or both directed against the respondent. manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: By order of the Commission. Issued: May 11, 2016. Lisa R. Barton, Secretary to the Commission. The company plans to manufacture reference standards for distribution to its research and forensics customers. In reference to drug codes 7360 (marihuana) and 7370 (THC) the company plans to manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. [FR Doc. 2016–11448 Filed 5–13–16; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: Organix, Inc. Notice of registration. asabaliauskas on DSK3SPTVN1PROD with NOTICES VerDate Sep<11>2014 18:48 May 13, 2016 Jkt 238001 I I I I I I II II Controlled substance Amphetamine (1100) .................... Methylphenidate (1724) ................ Nabilone (7379) ............................ Hydrocodone (9193) ..................... Alfentanil (9737) ........................... Remifentanil (9739) ...................... Sufentanil (9740) .......................... Schedule II II II II II II II [Docket No. DEA–392] The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company’s primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to its customers. Manufacturer of Controlled Substances Registration: Johnson Matthey Pharmaceutical Materials, Inc. Dated: May 9, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–11393 Filed 5–13–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Organix, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Organix, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated November 27, 2015, and published in the Federal Register on December 3, 2015, 80 FR 75691, Organix, Inc., 240 Salem Street, Woburn, Massachusetts 01801 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Organix, Inc. to SUMMARY: Gamma Hydroxybutyric Acid (2010). Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Psilocybin (7437) .......................... Psilocyn (7438) ............................. Heroin (9200) ............................... Lysergic acid diethylamide (7315) Morphine (9300) ........................... Schedule Dated: May 9, 2016. Louis J. Milione, Deputy Assistant Administrator. Drug Enforcement Administration ACTION: Controlled substance published in the Federal Register on December 8, 2015, 80 FR 76311, Johnson Matthey Pharmaceutical Materials, Inc., 25 Patton Road, Devens, Massachusetts 01434 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Pharmaceutical Materials, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: Drug Enforcement Administration ACTION: [FR Doc. 2016–11394 Filed 5–13–16; 8:45 am] Notice of registration. BILLING CODE 4410–09–P Johnson Matthey Pharmaceutical Materials, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey Pharmaceutical Materials, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated November 30, 2015, and SUMMARY: PO 00000 Frm 00107 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration: Siegfried USA, LLC ACTION: E:\FR\FM\16MYN1.SGM Notice of registration. 16MYN1 30344 Federal Register / Vol. 81, No. 94 / Monday, May 16, 2016 / Notices Siegfried USA, LLC applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Siegfried USA, LLC registration as an importer of those controlled substances. SUMMARY: By notice dated January 11, 2016, and published in the Federal Register on January 19, 2016, 81 FR 2910, Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070 applied to be registered as an importer of certain basic classes of controlled substances. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Siegfried USA, LLC to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Schedule Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) II II asabaliauskas on DSK3SPTVN1PROD with NOTICES The company plans to import the listed controlled substances to manufacture bulk active pharmaceutical ingredients (API) for distribution to its customer. Dated: April 28, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–11414 Filed 5–13–16; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 18:48 May 13, 2016 Jkt 238001 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: AMRI Rensselaer, Inc. ACTION: Notice of registration. In reference to drug codes 7360 (marihuana), and 7370 (THC), the company plans to bulk manufacture these drugs as synthetics. No other activity for these drug codes are authorized for this registration. Dated: April 28, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–11392 Filed 5–13–16; 8:45 am] AMRI Rensselaer, Inc. applied BILLING CODE 4410–09–P to be registered as a manufacturer of certain basic classes of controlled DEPARTMENT OF JUSTICE substances. The Drug Enforcement Administration (DEA) grants AMRI Drug Enforcement Administration Rensselaer, Inc. registration as a manufacturer of those controlled [Docket No. DEA–392] substances. Manufacturer of Controlled SUPPLEMENTARY INFORMATION: By notice Substances Registration: Johnson dated November 30, 2015, and Matthey, Inc. published in the Federal Register on December 8, 2015, 80 FR 76312, AMRI ACTION: Notice of registration. Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144 applied to SUMMARY: Johnson Matthey, Inc. applied be registered as a manufacturer of to be registered as a manufacturer of certain basic classes of controlled certain basic classes of controlled substances. No comments or objections substances. The Drug Enforcement were submitted for this notice. The DEA has considered the factors in Administration (DEA) grants Johnson Matthey, Inc. registration as a 21 U.S.C. 823(a) and determined that the registration of AMRI Rensselaer, Inc. manufacturer of those controlled substances. to manufacture the basic classes of controlled substances is consistent with SUPPLEMENTARY INFORMATION: By notice the public interest and with United dated December 9, 2015, and published States obligations under international in the Federal Register on December 17, treaties, conventions, or protocols in 2015, 80 FR 78765, Johnson Matthey, effect on May 1, 1971. The DEA Inc., Custom Pharmaceuticals investigated the company’s maintenance Department, 2003 Nolte Drive, West of effective controls against diversion by Deptford, New Jersey 08066–1742 inspecting and testing the company’s applied to be registered as a physical security systems, verifying the manufacturer of certain basic classes of company’s compliance with state and controlled substances. No comments or local laws, and reviewing the company’s objections were submitted for this background and history. notice. Therefore, pursuant to 21 U.S.C. The DEA has considered the factors in 823(a), and in accordance with 21 CFR 21 U.S.C. 823(a) and determined that 1301.33, the above-named company is the registration of Johnson Matthey, Inc. granted registration as a bulk to manufacture the basic classes of manufacturer of the following basic controlled substances is consistent with classes of controlled substances: the public interest and with United Controlled substance Schedule States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA Marihuana (7360) ......................... I Tetrahydrocannabinols (7370) ..... I investigated the company’s maintenance Amphetamine (1100) .................... II of effective controls against diversion by Lisdexamfetamine (1205) ............. II inspecting and testing the company’s Methylphenidate (1724) ................ II physical security systems, verifying the Pentobarbital (2270) ..................... II company’s compliance with state and 4-Anilino-N-phenethyl-4-piperidine II local laws, and reviewing the company’s (ANPP) (8333). background and history. Meperidine (9230) ........................ II Therefore, pursuant to 21 U.S.C. Fentanyl (9801) ............................ II 823(a), and in accordance with 21 CFR The company plans to manufacture 1301.33, the above-named company is bulk controlled substances for use in granted registration as a bulk product development and for manufacturer of the following basic distribution to its customers. classes of controlled substances: SUMMARY: PO 00000 Frm 00108 Fmt 4703 Sfmt 4703 E:\FR\FM\16MYN1.SGM 16MYN1

Agencies

[Federal Register Volume 81, Number 94 (Monday, May 16, 2016)]
[Notices]
[Pages 30343-30344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11414]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Siegfried USA, 
LLC

ACTION: Notice of registration.

-----------------------------------------------------------------------

[[Page 30344]]

SUMMARY: Siegfried USA, LLC applied to be registered as an importer of 
certain basic classes of controlled substances. The Drug Enforcement 
Administration (DEA) grants Siegfried USA, LLC registration as an 
importer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated January 11, 2016, and 
published in the Federal Register on January 19, 2016, 81 FR 2910, 
Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 
08070 applied to be registered as an importer of certain basic classes 
of controlled substances. Comments and requests for hearings on 
applications to import narcotic raw material are not appropriate. 72 FR 
3417, (January 25, 2007).
    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of Siegfried USA, LLC to 
import the basic classes of controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Opium, raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to 
manufacture bulk active pharmaceutical ingredients (API) for 
distribution to its customer.

    Dated: April 28, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-11414 Filed 5-13-16; 8:45 am]
 BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.